Bicalutamide design [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2008-03-26 17:32 (6668 d 20:01 ago) – Posting: # 1725
Views: 5,151

Dear Alhas!

❝ can any one suggest the blood sampling points for bicalutamide as the Tmax is around 31.3h (from US RLD label)


OK, you are talking about the active isomer R(-)bicalutamide.

Some points to consider:
You must be able to show descriptively data of the inactive S(+) isomer as well. This complicates things, because the tmax of S(+) is about 4 hours only (and t½ about 22 hours).
Therefore your sampling time points must be able to describe both profiles…
Due to the long half life of R(-) I would go with a parallel study; truncated AUC should do the job pretty well. In one study in 58 subjects we saw a tmax of R(-) in two subjects at 72 hours – to be on the safe side, I would sample until 96 hours.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
291 visitors (1 registered, 290 guests [including 21 identified bots]).
Forum time: 14:34 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5